Technology: Atrificial Vectors and Immune Cells, Cell-based gene therapy
Industry: Atrificial Vectors and Immune Cells, Private
Headquarters: South San Francisco, California, United States
Founded Date: 2020-01-01
Employees Number: 101-250
Investors Number: 24
Total Funding: 365000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2023-03-28
Last Funding Type: Corporate Round

Visit Website
contato@sonoma.com.br
https://twitter.com/sonomabio
Register and Claim Ownership